Bartter syndrome in two siblings--antenatal and neonatal observations.Willem Proesmans, Paul Lijnen, Hugo Devlieger et al.|PubMed|1985Cited by 38
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Geert Meyfroidt, Piet Maes et al.|Trials|2020Cited by 19
Absent or Reversed end Diastolic Flow in the Umbilical Arteries : A Warning Sign of Serious Fetal CompromiseWillem Ombelet, Ado Van Assche, S. Nuradi et al.|Clinical and Experimental Hypertension Part B Hypertension in Pregnancy|1988Cited by 5
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.Timothy Devos, Geert Meyfroidt, Tatjana Geukens et al.|Research Square|2020Cited by 2
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Geert Meyfroidt, Tatjana Geukens et al.|Trials|2020Cited by 1